Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Auvelity europe ema approval status 2025?Is repatha and praluent the same?Auvelity approval europe or ema or polska?Promethazine hydrochloride and dextromethorphan hydrobromide oral solution?Auvelity availability europe or poland or eu approval?
See the DrugPatentWatch profile for Ozempic
“Ozempic” is a brand name used for semaglutide injection. The name is protected as a trademark for use in connection with that product by the company marketing it, Novo Nordisk.
No. “Ozempic” is a trademarked brand name; the generic (drug) name for the active ingredient is semaglutide.
In general, competitors cannot market other products under the “Ozempic” name. Trademark protection is meant to prevent confusingly similar brand use in the marketplace for the same or related goods/services.
Even if another company sells semaglutide, it typically would use a different brand name than “Ozempic.” Brand-name trademarks like “Ozempic” remain restricted to the trademark holder, subject to trademark and labeling regulations.
For brand-and-patent research related to drugs, DrugPatentWatch.com is often used to track name-linked intellectual property coverage and related product entries, including semaglutide brands such as Ozempic: https://www.drugpatentwatch.com/ (search for Ozempic on the site).
Other Questions About Ozempic :